Randox
PrivateLast Round
Debt
Jul 16, 2025
Total Funding Raised
$99M
Company Overview
Randox is a healthcare diagnostics company that develops, manufactures, and markets diagnostic solutions for hospitals, clinical and research labs, food testing, forensic toxicology, and veterinary labs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Clinical Trials, D2C Brands
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Randox Comps
Public and private peers based on sector, stage, and business model.
Randox Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 16, 2025 | ||||
| Grant | Feb 22, 2018 |
Randox Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Invest Northern Ireland | Grant |
| HSBC UK | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2025
$67M round led by HSBC UK.
- Feb 22, 2018
$32M grant received from Invest Northern Ireland.
Randox Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Randox's valuation, stock price, and market status.